Losartan/hydrochlorothiazide is a combination of two drugs in a single form. It's used to treat high blood pressure. It's also used to reduce the risk of stroke in people with high blood pressure and a heart condition called left ventricular hypertrophy.

Market Analysis and Insights: Global and Japan Losartan and Hydrochlorothiazide Tablets Market
This report focuses on global and Japan Losartan and Hydrochlorothiazide Tablets market.
In 2020, the global Losartan and Hydrochlorothiazide Tablets market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027. In Japan the Losartan and Hydrochlorothiazide Tablets market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Losartan and Hydrochlorothiazide Tablets Scope and Market Size
Losartan and Hydrochlorothiazide Tablets market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Losartan and Hydrochlorothiazide Tablets market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For Japan market, this report focuses on the Losartan and Hydrochlorothiazide Tablets market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in Japan.

Segment by Type
50 mg/ 12.5 mg
100 mg/ 25 mg

Segment by Application
Hospital
Clinics
Recovery Center

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Alembic
Cadista
Lupin
Rising Pharmaceuticals
Sandoz
Teva
Merck
Torrent
Aurobindo